Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA

https://doi.org/10.1016/0197-0186(94)90001-9Get rights and content

Abstract

The heterocyclic analogue of (S)-glutamic acid, (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid [(S)-AMPA] is a potent and selective AMPA receptor agonist, whereas the enantiomeric compound, (R)-AMPA, is virtually inactive. We have previously characterized (RS)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(RS)-APPA] as a partial AMPA receptor agonist showing about 60% of the efficacy of (RS)-AMPA. This partial agonism produced by (RS)-APPA is, however, only apparent, since resolution of (RS)-APPA has now been shown to provide the full AMPA receptor agonist, (S)-APPA, whereas (R)-APPA is a non-N-methyl-d-aspartic acid (non-NMDA) receptor antagonist showing preferential AMPA blocking effects. In agreement with classical theories for competitive interaction between agonists and antagonists, the efficacy of depolarizations produced by (S)-APPA in the rat cortical wedge preparation was shown to be progressively reduced with increasing molar ratios of (R)-APPA/(S)-APPA. These compounds and the competitive antagonists (RS)-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid [(RS)-AMOA], 6-cyano-7-nitroquinoxalin-2,3-dione (CNQX) and 6-nitro-7-sulfamoylbenzo(f)quinoxalin-2,3-dione (NBQX) were also tested in [3H]AMPA and [3H]CNQX binding systems, the latter ligand being used in the absence or presence of thiocyanate ions. On the basis of these studies it is suggested that (RS)-AMPA and the AMPA agonist (S)-APPA interact with a high-affinity receptor conformation, whereas the competitive antagonists (RS)-AMOA and (R)-APPA, derived from these agonists, preferentially bind to a low-affinity AMPA receptor conformation. The competitive antagonists, CNQX and NBQX which are structurally unrelated to (RS)-AMPA or (RS)-APPA, do not seem to discriminate between these two AMPA receptor conformations. The modified [3H]CNQX binding assay containing thiocyanate ions was shown to provide receptor affinity data for AMPA receptor agonists as well as antagonists, which correlate with the potencies of these compounds in the cortical wedge preparation. Using autoradiographic techniques, (S)- and (R)-APPA were shown to exhibit significantly different absolute potencies as inhibitors of [3H]AMPA binding in a number of regions of the rat brain.

References (34)

  • I.T. Christensen et al.

    Excitatory amino acid receptor ligands

  • B. Ebert et al.

    Molecular pharmacology of cortical and spinal AMPA receptors

    Molec. Neuropharmac.

    (1992)
  • B. Ebert et al.

    Resolution, absolute stereochemistry and pharmacology of (S)-(+)- and (R)-(−)- isomers of the apparent partial AMPA receptor agonist (RS)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(RS)-APPA]

    J. med. Chem.

    (1994)
  • P.T. Francis et al.

    Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives

    J. Neurochem.

    (1993)
  • J.T. Greenamyre et al.

    Glutamate transmission and toxicity in Alzheimer's disease

    Prog. Neuro-Psychopharmac. Biol. Psychiat.

    (1988)
  • N.L. Harrison et al.

    Quantitative studies on some antagonists of N-methyl-d-aspartate in slices of rat cerebral cortex

    Br. J. Pharmac.

    (1985)
  • T. Honoré et al.

    Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes

    J. Neurochem.

    (1988)
  • Cited by (0)

    Part of this work was presented at the Excitatory Amino Acid Neurotransmission meeting, Marseilles, France, 29 August–2 September 1993, organized by Max Récasens.

    View full text